Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
Tazarotene vs. Tretinoin
San Francisco - Tazarotene 0.1 percent cream (Avage) and tretinoin 0.05 percent emollient cream (Renova) are both effective adjunctive agents for mitigating signs of facial photodamage, but results of a six-month, double-blind, parallel comparative trial indicate tazarotene offers the potential for earlier and greater results, said Nicholas J. Lowe, M.D.
Related Videos
Related Content
